Finance

Lists
GENIL:IST
Gen Ilac ve Saglik Urnlr Snyi ve Tcrt AS
TRY 12.05
+0.92%
(+0.11) 1D
Sep 11, 6:10:00 PM GMT+3  ·   TRY
All symbols
SymbolPriceChange% Change
Generating top insights for GENIL...
Open
TRY 11.99
High
TRY 12.24
Low
TRY 11.74
Mkt. cap
54.23B
Avg. vol.
47.55M
Volume
46.13M
Dividend
0.28%
Quarterly dividend
TRY 0.01
Ex-dividend date
Nov 12, 2025
P/E ratio
46.49
52-wk high
TRY 14.93
52-wk low
TRY 7.12
EPS
TRY 0.26
Shares outstanding
4.50B
No. of employees
689
Open
TRY 11.99
High
TRY 12.24
Low
TRY 11.74
Mkt. cap
54.23B
Avg. vol.
47.55M
Volume
46.13M
Dividend
0.28%
Quarterly dividend
TRY 0.01
Ex-dividend date
Nov 12, 2025
P/E ratio
46.49
52-wk high
TRY 14.93
52-wk low
TRY 7.12
EPS
TRY 0.26
Shares outstanding
4.50B
No. of employees
689
About Gen Ilac ve Saglik Urnlr Snyi ve Tcrt AS
CEO-
Employees689
Founded1998
Headquarters-
SectorPharmaceutical industry
Websitegenilac.com.tr
Previous reportsAll values in TRY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TRY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.35B
4.82B
7.09B
6.97B
Cost of goods sold
4.32B
3.75B
5.00B
5.48B
Cost of revenue
4.32B
3.75B
5.00B
5.48B
Research and development expenses
580.70K
21.03M
23.90M
51.05M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
501.22M
843.92M
806.92M
664.31M
Operating expense
426.35M
790.82M
880.32M
718.61M
Total operating expenses
4.75B
4.54B
5.88B
6.20B
Operating income
605.72M
283.17M
1.20B
765.26M
Other non operating income
-7.60M
-170.09M
-298.92M
61.07M
EBT including unusual items
341.19M
545.00M
555.09M
307.89M
EBT excluding unusual items
337.85M
525.72M
757.78M
281.24M
Income tax expense
127.68M
396.92M
154.40M
-180.82M
Effective tax rate
37.42%
72.83%
27.81%
-58.73%
Other operating expenses
-75.45M
-74.13M
49.51M
3.25M
Net income
215.77M
150.56M
401.45M
490.33M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
36.19M
685.62M
94.64M
76.42M
Interest expense
-228.09M
-269.26M
-258.79M
-552.43M
Net interest expenses
-191.90M
416.36M
-164.15M
-476.01M
Depreciation and amortization charges
-
-
-
-
EBITDA
759.45M
436.90M
1.34B
779.78M
Gain or loss from assets sale
-570.34K
-4.70M
-262.52K
-25.12M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps